chr19-5590352-G-T
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_014649.3(SAFB2):c.2451C>A(p.Asp817Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000108 in 1,611,466 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_014649.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
SAFB2 | NM_014649.3 | c.2451C>A | p.Asp817Glu | missense_variant | 18/21 | ENST00000252542.9 | |
SAFB2 | XM_011528449.4 | c.2451C>A | p.Asp817Glu | missense_variant | 18/21 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
SAFB2 | ENST00000252542.9 | c.2451C>A | p.Asp817Glu | missense_variant | 18/21 | 1 | NM_014649.3 | P1 | |
SAFB2 | ENST00000589925.1 | n.319C>A | non_coding_transcript_exon_variant | 4/5 | 3 |
Frequencies
GnomAD3 genomes AF: 0.0000986 AC: 15AN: 152192Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000576 AC: 14AN: 242908Hom.: 0 AF XY: 0.0000606 AC XY: 8AN XY: 132006
GnomAD4 exome AF: 0.000109 AC: 159AN: 1459274Hom.: 0 Cov.: 32 AF XY: 0.0000978 AC XY: 71AN XY: 725788
GnomAD4 genome AF: 0.0000986 AC: 15AN: 152192Hom.: 0 Cov.: 32 AF XY: 0.0000673 AC XY: 5AN XY: 74332
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 09, 2024 | The c.2451C>A (p.D817E) alteration is located in exon 18 (coding exon 18) of the SAFB2 gene. This alteration results from a C to A substitution at nucleotide position 2451, causing the aspartic acid (D) at amino acid position 817 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at